NCT04267471

Brief Summary

Several studies investigating Tai Chi for hypertension have been carried out. However, investigators found the results were in high heterogeneity and poor methodological quality. Thus, investigators intend to provide high quality of the effectiveness and safety of Tai Chi for essential hypertension.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
234

participants targeted

Target at P50-P75 for not_applicable hypertension

Timeline
Completed

Started Jun 2020

Typical duration for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 9, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 12, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

June 1, 2020

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

February 24, 2020

Status Verified

February 1, 2020

Enrollment Period

2.3 years

First QC Date

February 9, 2020

Last Update Submit

February 21, 2020

Conditions

Keywords

Tai ChiHypertensionRandomized Controlled Trial

Outcome Measures

Primary Outcomes (1)

  • average 24-h Systolic Blood Pressure (SBP)

    change from baseline to 12 weeks after intervention

Secondary Outcomes (7)

  • average SBP and average Diastolic Blood Pressure (DBP)

    baseline, after intervention(12 week), after follow-up(24 week)

  • change of serum concentrations of Nitric Oxide

    baseline, after intervention(12 week)

  • change of serum concentrations of endothelin

    baseline, after intervention(12 week)

  • change of serum concentrations of thromboxane A2

    baseline, after intervention(12 week)

  • change of serum concentrations of vascular endothelial growth factor

    baseline, after intervention(12 week)

  • +2 more secondary outcomes

Study Arms (3)

Tai Chi

EXPERIMENTAL

3 sessions of Tai Chi per week for 12 weeks

Behavioral: Tai Chi

Walking

ACTIVE COMPARATOR

3 sessions of walking per week for 12 weeks

Behavioral: Walking

Waiting-list

NO INTERVENTION

Interventions

Tai ChiBEHAVIORAL

Tai Chi is a traditional Chinese mind-body exercise, which combines deep-breath relaxation and gentle movements in sequence with meditation. Each session of Tai Chi will last 60 minutes, including a 10-minute warm-up, a 40-minute Tai Chi practice and a 10-minute cool-down.

Also known as: Tai Ji Quan
Tai Chi
WalkingBEHAVIORAL

Each session of walking will last 60 minutes, including a 10-minute warm-up, a 40-minute walking and a 10-minutes cool-down.

Walking

Eligibility Criteria

Age45 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • participants aged between 45 to 80 years;
  • participants diagnosed with mild to moderate hypertension, and meet the diagnostic criteria of mild to moderate hypertension according to 2018 Chinese guidelines for the management of hypertension (140≤SBP≤169 and/or 90≤DBP≤109);
  • participants with or without antihypertensive medication;
  • participants with no regular exercise in the past 3 months;
  • participants willing to comply with the study protocol;
  • participants willing to sign informed consent form.

You may not qualify if:

  • participants diagnosed with secondary hypertension or refractory hypertension;
  • participants with severe medical visceral condition and chronic diseases, such as diabetes, epilepsy, severe depression or anxiety, psychosis;
  • participants with severe bone and joint diseases or motor dysfunction limit ability to participant exercise;
  • participants with severe cognitive decline (Mini-Mental State Examination score, ≤ 20)
  • participants with weak muscle, poor balance or limited vision that would impede full participation in the study;
  • patients participate in other clinical trials at the same time.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine (Sichuan Provincial Hospital of Traditional Chinese Medicine)

Chengdu, Sichuan, 610075, China

Location

Related Publications (1)

  • Li Y, Zhong D, Dong C, Shi L, Zheng Y, Liu Y, Li Q, Zheng H, Li J, Liu T, Jin R. The effectiveness and safety of Tai Chi for patients with essential hypertension: study protocol for an open-label single-center randomized controlled trial. BMC Complement Med Ther. 2021 Jan 7;21(1):23. doi: 10.1186/s12906-020-03192-z.

MeSH Terms

Conditions

Hypertension

Interventions

Tai JiWalking

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy ModalitiesLocomotionMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExerciseMotor Activity

Study Officials

  • Youping Liu, PhD

    Chengdu University of Traditional Chinese Medicine

    STUDY CHAIR

Central Study Contacts

Rongjiang Jin, PhD

CONTACT

Juan Li, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 9, 2020

First Posted

February 12, 2020

Study Start

June 1, 2020

Primary Completion

September 1, 2022

Study Completion

December 1, 2022

Last Updated

February 24, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations